Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.
about
Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicabilityPredictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's DiseaseA novel method predicting clinical response using only background clinical data in RA patients before treatment with infliximab.An integrated microfluidic platform for in situ cellular cytokine secretion immunophenotypingEarly Prognostic Factors Associated with the Efficacy of Infliximab Treatment for Patients with Rheumatoid Arthritis with Inadequate Response to Methotrexate.ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF+ T Lymphocytes.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis.[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients
P2860
Q26771652-52EFBC30-8295-4D2C-9281-0FA66D1A664FQ27692641-E1AA37AA-0281-4B9B-BB12-4489043EE6BAQ28546744-113E136D-4E60-4EC7-9856-8DEEEE662E58Q31090628-A6D16302-9CCA-4AF9-B92F-59242C5974E1Q36427709-8138BFA6-46E0-4689-AC52-91551FB26B2CQ37208439-1B9BBC23-C836-4117-A325-7F15FEA262D3Q37691090-5F5A857E-4F39-4795-9DB0-566E64D49F0DQ42113714-4E959621-1F97-4B17-9069-FE98DBB38DDAQ42633541-8F2A1B1A-8513-4875-9E60-28EEBBDD25D8Q50918813-C2F9AFD1-AB64-4EEB-B4B5-36F4F597FE0CQ52862596-D4729464-03F6-4B42-A142-B09A9E7D5CF8Q58719858-EE3B4974-362C-4319-9560-FFCA4044C5F3
P2860
Interleukin-1β measurement in stimulated whole blood cultures is useful to predict response to anti-TNF therapies in rheumatoid arthritis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@en
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@nl
type
label
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@en
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@nl
prefLabel
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@en
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@nl
P2093
P356
P1433
P1476
Interleukin-1β measurement in ...... apies in rheumatoid arthritis.
@en
P2093
Akito Maeshima
Anastasie Tshilela Kadiombo
Keiju Hiromura
Ken Kayakabe
Noriyuki Sakurai
Takashi Kuroiwa
Toru Sakairi
Yoriaki Kaneko
Yoshihisa Nojima
P304
P356
10.1093/RHEUMATOLOGY/KES094
P577
2012-05-16T00:00:00Z